ForCast Orthopedics recently announced that it won the Shark Tank competition at the Anterior Hip Foundation (AHF) meeting held in Nashville on June 6, 2025.
Among seven companies pitching to a panel of five experts, ForCast was recognized for its groundbreaking approach to the treatment of periprosthetic joint infection (PJI).
PJI is a rare but serious complication of joint replacement procedures that can threaten the function of the joint, the preservation of the limb and even the life of the patient. PJI is challenging to treat because the infecting bacteria adhere to the prothesis and form a protective biofilm that can be resistant to standard systemic antibiotics. ForCast intends to address these challenges by developing a portfolio of targeted antibiotic therapies delivered directly into the infected joint using ForCast’s proprietary technology.
“We were honoured to be invited to present to AHF’s Shark Tank panel, and thrilled to learn that we had won,” said Peter Noymer, Executive Chairman and CEO of ForCast. “This external validation of our core technology and its ability to address the critical unmet need in PJI is extremely meaningful as we move forward with our development programs.”
The AHF is the foremost incubator for the anterior approach total hip arthroplasty procedure and is a collaborative between orthopaedic surgeons aiming to continue improving patient care. AHF’s Shark Tank panel started in 2021 as a way to further that spirit of innovation.
Follow this link for more information about the 2025 AHF meeting.
Follow this link for more information about the 2025 AHF Shark Tank competition.
Image: ForCast Leadership: Peter Noymer, CEO and Jared Foran, MD Founder
Dr. Jared Foran, MD and Peter Noymer, their innovative drug-delivery catheter, designed to administer antibiotics directly to the infection site, won over both the Sharks and the audience. Submitted with news release
